A study to compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 with US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-523115-11-00

Acronym

A160_01AD2502

Enrollment

335

Registered

2026-01-09

Start date

2026-01-14

Completion date

Unknown

Last updated

2026-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

and chronic obstructive pulmonary disease, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, Phase I study in healthy participants. Intended indication: atopic dermatitis, prurigo nodularis

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Countries

Germany

Outcome results